Viewing Study NCT05220020


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-02-05 @ 11:55 PM
Study NCT ID: NCT05220020
Status: UNKNOWN
Last Update Posted: 2022-05-19
First Post: 2022-01-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module